Concepts (124)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lymphoma, T-Cell, Peripheral | 2 | 2022 | 122 | 1.460 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 3 | 2017 | 202 | 1.390 |
Why?
|
Lymphoma, T-Cell | 3 | 2022 | 298 | 1.260 |
Why?
|
Mucin-1 | 4 | 2017 | 532 | 1.070 |
Why?
|
Nuclear Physics | 6 | 2014 | 71 | 0.740 |
Why?
|
Azacitidine | 2 | 2019 | 298 | 0.720 |
Why?
|
Antigens, Differentiation | 1 | 2019 | 964 | 0.590 |
Why?
|
Receptors, IgG | 1 | 2019 | 611 | 0.570 |
Why?
|
Elementary Particles | 4 | 2014 | 52 | 0.490 |
Why?
|
Receptors, Immunologic | 1 | 2019 | 1477 | 0.470 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2017 | 3633 | 0.460 |
Why?
|
Oxidative Stress | 2 | 2017 | 3129 | 0.350 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2022 | 11236 | 0.340 |
Why?
|
Models, Theoretical | 6 | 2014 | 3579 | 0.300 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2022 | 8896 | 0.250 |
Why?
|
Elementary Particle Interactions | 2 | 2013 | 17 | 0.240 |
Why?
|
Registries | 1 | 2019 | 8048 | 0.230 |
Why?
|
Peptides | 1 | 2015 | 4384 | 0.230 |
Why?
|
Cell Proliferation | 2 | 2017 | 10615 | 0.230 |
Why?
|
Ifosfamide | 1 | 2022 | 221 | 0.220 |
Why?
|
Apoptosis | 2 | 2017 | 9971 | 0.220 |
Why?
|
Cancer Vaccines | 3 | 2019 | 997 | 0.220 |
Why?
|
Ikaros Transcription Factor | 1 | 2022 | 221 | 0.200 |
Why?
|
Cell Line, Tumor | 7 | 2019 | 16735 | 0.200 |
Why?
|
Molecular Targeted Therapy | 1 | 2012 | 2824 | 0.190 |
Why?
|
Reactive Oxygen Species | 2 | 2017 | 2099 | 0.170 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2022 | 675 | 0.170 |
Why?
|
Leukemia, Myeloid, Acute | 3 | 2019 | 3294 | 0.170 |
Why?
|
Multiple Myeloma | 3 | 2022 | 4969 | 0.160 |
Why?
|
Mesons | 2 | 2014 | 27 | 0.150 |
Why?
|
Disease Models, Animal | 2 | 2019 | 18197 | 0.150 |
Why?
|
Skin Neoplasms | 1 | 2015 | 5318 | 0.150 |
Why?
|
Receptors, Fc | 1 | 2019 | 561 | 0.140 |
Why?
|
Aminopterin | 1 | 2015 | 16 | 0.140 |
Why?
|
Depsipeptides | 1 | 2015 | 86 | 0.130 |
Why?
|
NADP | 1 | 2015 | 255 | 0.130 |
Why?
|
Neutrons | 1 | 2014 | 77 | 0.130 |
Why?
|
Flow Cytometry | 2 | 2015 | 6093 | 0.130 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2015 | 410 | 0.120 |
Why?
|
Luminescent Measurements | 1 | 2015 | 376 | 0.120 |
Why?
|
Cell Communication | 2 | 2017 | 1635 | 0.110 |
Why?
|
Antigens, Neoplasm | 2 | 2017 | 1987 | 0.110 |
Why?
|
Glutathione | 1 | 2015 | 606 | 0.110 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2022 | 1842 | 0.110 |
Why?
|
Immunologic Factors | 1 | 2022 | 1571 | 0.110 |
Why?
|
Immunoenzyme Techniques | 1 | 2015 | 1833 | 0.110 |
Why?
|
Oxidation-Reduction | 1 | 2017 | 2299 | 0.110 |
Why?
|
Stromal Cells | 1 | 2017 | 1338 | 0.100 |
Why?
|
Antineoplastic Agents | 3 | 2017 | 13626 | 0.100 |
Why?
|
Necrosis | 1 | 2015 | 1645 | 0.100 |
Why?
|
Remission Induction | 1 | 2016 | 2394 | 0.100 |
Why?
|
Mice | 5 | 2019 | 80373 | 0.100 |
Why?
|
Mice, Inbred NOD | 1 | 2015 | 1904 | 0.100 |
Why?
|
Drug Synergism | 1 | 2015 | 1853 | 0.100 |
Why?
|
Tumor Microenvironment | 2 | 2019 | 3054 | 0.100 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2015 | 1116 | 0.090 |
Why?
|
Dendritic Cells | 2 | 2019 | 2699 | 0.090 |
Why?
|
Immunotherapy, Adoptive | 1 | 2017 | 1017 | 0.090 |
Why?
|
Mice, SCID | 1 | 2015 | 2787 | 0.090 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2022 | 5198 | 0.090 |
Why?
|
Coculture Techniques | 3 | 2017 | 1353 | 0.090 |
Why?
|
Disease-Free Survival | 1 | 2019 | 7015 | 0.080 |
Why?
|
Protons | 1 | 2013 | 1065 | 0.080 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2019 | 4262 | 0.080 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 4893 | 0.080 |
Why?
|
Blotting, Western | 1 | 2015 | 5378 | 0.080 |
Why?
|
Tumor Cells, Cultured | 1 | 2015 | 6482 | 0.080 |
Why?
|
Bone Marrow | 1 | 2017 | 2926 | 0.070 |
Why?
|
Animals | 6 | 2019 | 169404 | 0.070 |
Why?
|
Transfection | 1 | 2015 | 6089 | 0.070 |
Why?
|
Graft vs Host Disease | 1 | 2018 | 2807 | 0.070 |
Why?
|
Humans | 14 | 2022 | 715818 | 0.070 |
Why?
|
Vaccination | 1 | 2016 | 2938 | 0.070 |
Why?
|
Immunosuppressive Agents | 1 | 2018 | 4193 | 0.060 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2015 | 2977 | 0.060 |
Why?
|
Survival Rate | 1 | 2019 | 13213 | 0.060 |
Why?
|
T-Lymphocytes | 2 | 2018 | 10284 | 0.060 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2017 | 8571 | 0.050 |
Why?
|
RNA, Messenger | 1 | 2015 | 13212 | 0.050 |
Why?
|
Cross-Priming | 1 | 2017 | 77 | 0.040 |
Why?
|
Perforin | 1 | 2017 | 171 | 0.040 |
Why?
|
Ubiquitination | 1 | 2022 | 989 | 0.040 |
Why?
|
Case-Control Studies | 1 | 2015 | 21795 | 0.040 |
Why?
|
Follow-Up Studies | 1 | 2019 | 39305 | 0.040 |
Why?
|
Virus Activation | 1 | 2019 | 329 | 0.040 |
Why?
|
Thalidomide | 1 | 2022 | 892 | 0.040 |
Why?
|
Retroviridae | 1 | 2019 | 955 | 0.040 |
Why?
|
Isoantigens | 1 | 2017 | 582 | 0.030 |
Why?
|
Signal Transduction | 2 | 2017 | 23729 | 0.030 |
Why?
|
Neoplasm Transplantation | 1 | 2019 | 2124 | 0.030 |
Why?
|
Janus Kinase 2 | 1 | 2017 | 516 | 0.030 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2017 | 1487 | 0.030 |
Why?
|
Prednisone | 1 | 2018 | 1546 | 0.030 |
Why?
|
Electrons | 1 | 2014 | 263 | 0.030 |
Why?
|
Thermodynamics | 1 | 2014 | 600 | 0.030 |
Why?
|
Immunity, Cellular | 1 | 2019 | 1684 | 0.030 |
Why?
|
STAT3 Transcription Factor | 1 | 2017 | 891 | 0.030 |
Why?
|
Aged | 3 | 2019 | 162468 | 0.030 |
Why?
|
Female | 4 | 2019 | 377229 | 0.030 |
Why?
|
Neoplasm, Residual | 1 | 2016 | 986 | 0.030 |
Why?
|
Down-Regulation | 1 | 2019 | 3066 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2017 | 987 | 0.030 |
Why?
|
Immune System | 1 | 2016 | 798 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 2017 | 1726 | 0.020 |
Why?
|
Adult | 3 | 2019 | 212279 | 0.020 |
Why?
|
Middle Aged | 3 | 2019 | 214666 | 0.020 |
Why?
|
Gene Silencing | 1 | 2017 | 1606 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 2018 | 4825 | 0.020 |
Why?
|
Interferon-gamma | 1 | 2017 | 3250 | 0.020 |
Why?
|
Glucocorticoids | 1 | 2018 | 2103 | 0.020 |
Why?
|
Male | 3 | 2019 | 350352 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2017 | 5853 | 0.020 |
Why?
|
DNA Methylation | 1 | 2019 | 4078 | 0.020 |
Why?
|
Gene Expression | 1 | 2017 | 7954 | 0.010 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2016 | 3045 | 0.010 |
Why?
|
Chronic Disease | 1 | 2018 | 9034 | 0.010 |
Why?
|
Cytokines | 1 | 2017 | 7189 | 0.010 |
Why?
|
MicroRNAs | 1 | 2017 | 3637 | 0.010 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2018 | 5113 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2019 | 22663 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2017 | 11655 | 0.010 |
Why?
|
Cohort Studies | 1 | 2018 | 40032 | 0.010 |
Why?
|
Young Adult | 1 | 2018 | 56228 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2016 | 62040 | 0.010 |
Why?
|
Concepts
(124)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(49)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_